Q-Cells will offer owners of its ordinary and preference shares one new share for every two they currently own. It will also issue a €130m ($174.6m) bond convertible into ordinary shares in 2015 to help refinance its existing €492.5m convertible bond, set to mature in early 2012.
The moves are intended “to secure the medium-term financing of the company at an early stage”, it says.
Q-Cells’
